Ebola: Looking Back on a Crisis and a Calling
ABSTRACT: Two U.S. nurses relay their experience of deciding to serve and work in Sierra Leone during the 2015 Ebola crisis. The nurses' heartbreaking experiences convey the devastation of Ebola in West Africa and the privilege of answering God's call to serve. Learn about the current status and known outcomes of Ebola Virus Disease (EVD) as of March 2016 for infected patients and the people of West Africa.
An Ebola survivor has fallen ill with the disease for a second time in eastern Congo, the Congolese health authorities said on Sunday, saying it was not yet clear if it was a case of relapse or reinfection.
Up to 200,000 Regimens of Janssen ’s Investigational Ebola Vaccine to be Supplied to Rwanda for Use in Border Region near Democratic Republic of the Congo (DRC)
[Daily News] THE East African Legislative Assembly (EALA) has adopted a report of the Committee on General Purpose on the oversight activity assessing levels of preparedness of partner states in management of epidemics, particularly Ebola and Dengue.
Violence against health workers in the Democratic Republic of Congo is complicating the response to a massive measles outbreak and accelerating the spread of the disease, which has claimed twice as many lives than an ongoing Ebola epidemic.
- A stockpile of 500,000 doses of Ebola vaccine for emergency use in outbreaks of the deadly fever is being established by the global vaccine alliance GAVI.
Vaccine alliance announces creation of Ebola vaccine stockpile of about 500,000 doses
[WHO] Kinshasa, 5 December 2019 - Around 2.2 million children are to be vaccinated against measles in North Kivu, the Democratic Republic of the Congo (DRC), where efforts are underway to curb the world's second-worst Ebola outbreak amid persistent insecurity.
Nine new confirmed cases were reported from 27 November to 3 December in the ongoing Ebola virus disease (EVD) outbreak in North Kivu and Ituri provinces. The confirmed cases in this week were reported from Mandima (56%,n=5) and Mabalako (44%,n=4) Health Zones. In the past two weeks, violence, widespread civil unrest, and targeted attacks have severely disrupted the Ebola response and restricted access to affected communities in multiple locations. As a result, several key activities of the response experienced diminished performance, including the volume of reported and investigated alerts and the number of contacts regis...
We report a candidate lead (compound #5: ((10R)-10-(4-hydroxyphenyl)-11,12,14,16-tetraazatetracyclo[7.7.0.02,7.011,15] hexadeca-1(16), 2(7),3,5,8,12,14-heptaen-8-ol)) with high drug-likeness score, promising lead-likeness behaviour and high median lethal dose. The candidate lead compound #5 engages in hydrogen bonding and hydrophobic interactions with VP40 active site residues. Thus, the lead compound #5 is recommended for further in vitro and in vivo validations for further consideration. PMID: 31787811 [PubMed]
Condition: Ebola Virus Disease Intervention: Biological: Ad26.ZEBOV vaccine Sponsors: Universiteit Antwerpen; Johnson & Johnson; Ace Africa; Innovative Medicines Initiative; Coalition for epidemic prepardness innovations; University of Kinshasa Not yet recruiting